Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
Go back to Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.38 -0.02 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.40 | 52 Week High | $3.50 | |||
| Open | $1.38 | 52 Week Low | $0.86 | |||
| Day High | $1.41 | P/E | N/A | |||
| Day Low | $1.33 | EPS | $-7.61 | |||
| Volume | 358,228 | |||||
| CORMEDIX, Inc. (NASDAQ: CRMD) | Delayed: 7.79 +0.22 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.57 | 52 Week High | $4.54 | |||
| Open | $7.55 | 52 Week Low | $1.15 | |||
| Day High | $7.85 | P/E | N/A | |||
| Day Low | $7.51 | EPS | $-0.55 | |||
| Volume | 1,049,667 | |||||
| (NASDAQ: OVID) | Delayed: 2.47 +0.11 (4.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.36 | 52 Week High | $ | |||
| Open | $2.37 | 52 Week Low | $ | |||
| Day High | $2.65 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $ | |||
| Volume | 5,005,133 | |||||



